Keywords: orapharma, mucositis, drug, track, successfully, completed, phase

OraPharma mucositis drug on track

Article | 12 August 2002

Print This

OraPharma has successfully completed a Phase I clinical trial of itssecond product candidate, OC-1012 for the prevention of mucositis, at ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in